Anlu Wang

813 total citations
20 papers, 569 citations indexed

About

Anlu Wang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Anlu Wang has authored 20 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Anlu Wang's work include Metabolomics and Mass Spectrometry Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Gut microbiota and health (3 papers). Anlu Wang is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Gut microbiota and health (3 papers). Anlu Wang collaborates with scholars based in China. Anlu Wang's co-authors include Baoyi Guan, Hao Xu, Keji Chen, Jixian Zhang, Cong He, Qing Miao, Yihan Yu, Wenguang Xia, Bo Xu and Haiping Hao and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Nutrients.

In The Last Decade

Anlu Wang

19 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anlu Wang China 9 207 156 136 96 89 20 569
Jianlei Cao China 13 345 1.7× 205 1.3× 232 1.7× 116 1.2× 146 1.6× 31 816
Qingsong Xia China 10 216 1.0× 150 1.0× 140 1.0× 75 0.8× 44 0.5× 12 541
Shahla Rezaei Iran 10 173 0.8× 83 0.5× 95 0.7× 158 1.6× 49 0.6× 31 601
Peyman Nowrouzi‐Sohrabi Iran 10 187 0.9× 65 0.4× 99 0.7× 94 1.0× 58 0.7× 29 557
Stephany Beyerstedt Brazil 4 332 1.6× 107 0.7× 162 1.2× 47 0.5× 44 0.5× 11 593
Margaret Zhou United States 10 98 0.5× 270 1.7× 50 0.4× 88 0.9× 148 1.7× 28 700
Cheng Tian China 10 563 2.7× 136 0.9× 285 2.1× 224 2.3× 97 1.1× 34 913
Manasvi Gupta United States 12 90 0.4× 142 0.9× 49 0.4× 53 0.6× 38 0.4× 28 685
Yongwen Feng China 9 154 0.7× 126 0.8× 101 0.7× 155 1.6× 34 0.4× 30 528
Shiva Samavat Iran 15 92 0.4× 140 0.9× 47 0.3× 89 0.9× 49 0.6× 47 606

Countries citing papers authored by Anlu Wang

Since Specialization
Citations

This map shows the geographic impact of Anlu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anlu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anlu Wang more than expected).

Fields of papers citing papers by Anlu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anlu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anlu Wang. The network helps show where Anlu Wang may publish in the future.

Co-authorship network of co-authors of Anlu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Anlu Wang. A scholar is included among the top collaborators of Anlu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anlu Wang. Anlu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qiyu, et al.. (2025). The effects of Songling Xuemaikang capsule on vascular remodeling of stage 1 hypertension: a multicenter, randomized placebo-controlled trial protocol. BMC Complementary Medicine and Therapies. 25(1). 300–300. 1 indexed citations
2.
Wang, Anlu, et al.. (2024). Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism. Pharmacological Research. 209. 107413–107413. 6 indexed citations
3.
Li, Qiuyi, Mei‐Ying Chang, Runmin Lai, et al.. (2023). Potential benefits of spicy food consumption on cardiovascular outcomes in patients with diabetes: A cohort study of the China Kadoorie Biobank. Nutrition. 112. 112062–112062. 3 indexed citations
4.
Liu, Shi, et al.. (2023). Remnant cholesterol associates with hypertension beyond low-density lipoprotein cholesterol among the general US adult population. Frontiers in Endocrinology. 14. 1260764–1260764. 11 indexed citations
5.
Guan, Baoyi, et al.. (2023). Causal associations of remnant cholesterol with cardiometabolic diseases and risk factors: a mendelian randomization analysis. Cardiovascular Diabetology. 22(1). 207–207. 24 indexed citations
6.
7.
Wang, Anlu, et al.. (2023). Danger-associated metabolites trigger metaflammation: A crowbar in cardiometabolic diseases. Pharmacological Research. 198. 106983–106983. 2 indexed citations
8.
Guan, Baoyi, Dan Ma, Yixuan Fan, et al.. (2022). The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis. Frontiers in Cardiovascular Medicine. 8. 820604–820604. 4 indexed citations
9.
Li, Qiuyi, Mei‐Ying Chang, Xinyi Wang, et al.. (2022). Efficacy and safety of drug-coated balloon in the treatment of acute myocardial infarction: a meta-analysis of randomized controlled trials. Scientific Reports. 12(1). 6552–6552. 6 indexed citations
10.
Wang, Anlu, Baoyi Guan, Chang Shao, et al.. (2022). Qing-Xin-Jie-Yu Granule alleviates atherosclerosis by reshaping gut microbiota and metabolic homeostasis of ApoE-/- mice. Phytomedicine. 103. 154220–154220. 29 indexed citations
11.
12.
Guan, Baoyi, Haiping Hao, Zhixu Yang, et al.. (2021). Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. Acta Pharmaceutica Sinica B. 12(5). 2129–2149. 133 indexed citations
13.
Wang, Anlu, Jie Zhang, Yan Zhang, et al.. (2020). Adjuvant Effects of Health Education of Chinese Medicine for Chronic Diseases: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2020(1). 3738753–3738753. 2 indexed citations
14.
Xu, Bo, Anlu Wang, Yihan Yu, et al.. (2020). Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China. Journal of Infection. 81(1). e51–e60. 225 indexed citations
15.
Xu, Bo, Anlu Wang, Yihan Yu, et al.. (2020). Suppressed T Cell-Mediated Immunity in Patients with COVID-19: A Clinical Retrospective Study in Wuhan, China. SSRN Electronic Journal. 15 indexed citations
16.
Chen, Zhuo, Xiang Gao, Yang Jiao, et al.. (2019). Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway. Frontiers in Pharmacology. 10. 850–850. 51 indexed citations
17.
Wang, Anlu, et al.. (2019). Using herbal medicine to target the “microbiota-metabolism-immunity” axis as possible therapy for cardiovascular disease. Pharmacological Research. 142. 205–222. 33 indexed citations
18.
Luo, Jing, Anlu Wang, Hao Xu, Dazhuo Shi, & Keji Chen. (2016). Expecting the holistic regulation from Chinese medicine based on the “solar system” hypothesis of ischemic heart disease. Chinese Journal of Integrative Medicine. 22(11). 805–810. 1 indexed citations
19.
Wang, Anlu, Zhuo Chen, Jing Luo, Qinghua Shang, & Hao Xu. (2015). Systematic review on randomized controlled trials of coronary heart disease complicated with depression treated with Chinese herbal medicines. Chinese Journal of Integrative Medicine. 22(1). 56–66. 7 indexed citations
20.
Wang, Anlu, et al.. (2015). [Practical Diagnostic Criterion of Blood Stasis Syndrome: Introduction, Reliability, and Validity].. PubMed. 35(8). 950–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianlei Cao Breakdown of academic impact, for papers by Qingsong Xia Breakdown of academic impact, for papers by Shahla Rezaei Breakdown of academic impact, for papers by Peyman Nowrouzi‐Sohrabi Breakdown of academic impact, for papers by Stephany Beyerstedt Breakdown of academic impact, for papers by Margaret Zhou Breakdown of academic impact, for papers by Cheng Tian Breakdown of academic impact, for papers by Manasvi Gupta Breakdown of academic impact, for papers by Yongwen Feng Breakdown of academic impact, for papers by Shiva Samavat
Rankless by CCL
2026